On November 6, 2025, UroGen Pharma Ltd. (NASDAQ:URGN) reported its Q3 2025 results, highlighting strong growth in demand ...

On November 10, 2025, The Fly reported that H.C. Wainwright increased its price target on Vera Therapeutics, Inc.

On November 6, 2025, RBC Capital raised its price target on Viridian Therapeutics, Inc. (NASDAQ:VRDN) from $41 to $45, while ...

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) reported its Q3 2025 results on November 6, 2025. The quarter marked continued ...

On November 10, 2025, BMO Capital reiterated its “Outperform” rating on Structure Therapeutics Inc. (NASDAQ:GPCR), setting a ...

Janux Therapeutics, Inc. (NASDAQ: JANX) is one of the best small-cap biotech stocks to buy according to analysts.

On November 11, 2025, William Blair kept its “Market Perform” rating. The investment firm sees the FDA’s Complete Response ...

Wave Life Sciences Ltd. (NASDAQ:WVE), a clinical-stage biotech company, develops and commercializes ribonucleic acid (RNA) medicines with the help of its proprietary PRISM discovery and drug ...

On November 12, 2025, Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) saw JPMorgan reduce its price target from $40 to $33, while ...

A report by the Wall Street Journal said Wednesday that the two companies are now underway negotiations for the potential ...

Ondas Holdings soared by 23.58 percent week-on-week as investors took heart from an investment firm’s bullish outlook for the ...